English | Español

Regulatory
+ Regulatory
Amanda Rupp | Aug 6, 2016

Adlyxin receives FDA approval as type 2 diabetes treatment
+ Technology/Innovation
Amanda Rupp | Aug 6, 2016

New software created to facilitate developing drugs
+ Technology/Innovation
Amanda Rupp | Aug 6, 2016

AbbVie launches venetoclax study for relapsed or refractory multiple myeloma
+ Technology/Innovation
Amanda Rupp | Aug 6, 2016

Known regions of human cortex increase with Human Connectome Project
+ Community
Amanda Rupp | Aug 6, 2016

NIH names new National Institute of Mental Health director
+ Community
Amanda Rupp | Aug 6, 2016

ADA recognizes new health advocates in U.S. organizations, companies
+ Regulatory
Amanda Rupp | Aug 5, 2016

Proposed rule from CMS features progress for cardiac patients
+ Community
Amanda Rupp | Aug 5, 2016

Astellas employees offer opportunities to Vancouver's Native youth

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation